Improving Benefit-harm Assessment of Therapies from the Patient Perspective: OMERACT Premeeting Toward Consensus on Core Sets for Randomized Controlled Trials

Andersen Kathleen M.; Cheah Jonathan T. L.; March Lyn; Bartlett Susan J.; Beaton Dorcas; Bingham Clifton O. III; Brooks Peter M.; Christensen Robin; Conaghan Philip G.; DAgostino Maria-Antonietta; de Wit Maarten; Dueck Amylou C.; Goodman Susan M.; Grosskleg Shawna; Hill Catherine L.; Howell Martin; Mackie Sarah L.; Richards Bethan; Shea Beverly; Singh Jasvinder A.; Strand Vibeke; Tugwell Peter; Wells George A.; Simon Lee S.

首页> 外文期刊>The Journal of rheumatology >Improving Benefit-harm Assessment of Therapies from the Patient Perspective: OMERACT Premeeting Toward Consensus on Core Sets for Randomized Controlled Trials

【24h】

Improving Benefit-harm Assessment of Therapies from the Patient Perspective: OMERACT Premeeting Toward Consensus on Core Sets for Randomized Controlled Trials

机译：从患者的角度提高疗效损害评估：Omeract关于随机对照试验的核心集合的共识

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Objective. Outcome Measures in Rheumatology (OMERACT) convened a premeeting in 2018 to bring together patients, regulators, researchers, clinicians, and consumers to build upon previous OMERACT drug safety work, with patients fully engaged throughout all phases.

机译：客观的。风湿病学的结果措施（Obseract）于2018年召开了一部分，将患者，监管机构，研究人员，临床医生和消费者汇集在一起以前的杂乱药物安全工作，患者在整个阶段完全参与。

著录项

来源
《The Journal of rheumatology》 |2019年第8期|共6页
作者
Andersen Kathleen M.; Cheah Jonathan T. L.; March Lyn; Bartlett Susan J.; Beaton Dorcas; Bingham Clifton O. III; Brooks Peter M.; Christensen Robin; Conaghan Philip G.; DAgostino Maria-Antonietta; de Wit Maarten; Dueck Amylou C.; Goodman Susan M.; Grosskleg Shawna; Hill Catherine L.; Howell Martin; Mackie Sarah L.; Richards Bethan; Shea Beverly; Singh Jasvinder A.; Strand Vibeke; Tugwell Peter; Wells George A.; Simon Lee S.;
展开▼
作者单位

McGill Univ Dept Family Med 5858 Chemin Cote des Neiges Montreal PQ H3S 1Z1 Canada;

Weill Cornell Med Div Rheumatol Hosp Special Surg New York NY USA;

Univ Sydney Sydney Med Sch Sydney NSW Australia;

McGill Univ Dept Med Montreal PQ Canada;

Inst Work &

Hlth Toronto ON Canada;

Johns Hopkins Univ Dept Med Div Rheumatol Baltimore MD USA;

Univ Melbourne Sch Populat &

Global Hlth Ctr Hlth Policy Melbourne Vic Australia;

Odense Univ Hosp Dept Rheumatol Odense Denmark;

Univ Leeds Leeds Inst Rheumat &

Musculoskeletal Med Leeds W Yorkshire England;

Hop Ambroise Pare Rheumatol Boulogne France;

Univ Amsterdam Med Ctr Dept Med Humanities Amsterdam Publ Hlth Amsterdam Netherlands;

Mayo Clin Dept Hlth Sci Res Div Biostat Scottsdale AZ USA;

Weill Cornell Med Sch Clin Med Div Rheumatol Hosp Special Surg New York NY USA;

OMERACT Ottawa ON Canada;

Univ Adelaide Discipline Med Adelaide SA Australia;

Univ Sydney Sydney Sch Publ Hlth Sydney NSW Australia;

Univ Leeds NIHR Leeds Musculoskeletal Biomed Res Unit Leeds W Yorkshire England;

Royal Prince Alfred Hosp Dept Rheumatol Camperdown NSW Australia;

Univ Ottawa Fac Med Ottawa Hosp Res Inst Ottawa Hosp Ottawa ON Canada;

Univ Alabama Birmingham Sch Med Med Serv VA Med Ctr Birmingham AL USA;

Univ Ottawa Fac Med Div Rheumatol Dept Med Ottawa ON Canada;

Univ Ottawa Sch Epidemiol &

Publ Hlth Ottawa ON Canada;

SDG LLC Cambridge MA USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类免疫性疾病;
关键词
OMERACT; PATIENT SATISFACTION; CLINICAL TRIALS; DISEASE-MODIFYING ANTIRHEUMATIC DRUGS; RISK ASSESSMENT;

机译：杂乱无章;患者满意度;临床试验;疾病修饰的抗抗毒药;风险评估;

相似文献

外文文献
中文文献
专利

1. Improving Benefit-harm Assessment of Therapies from the Patient Perspective: OMERACT Premeeting Toward Consensus on Core Sets for Randomized Controlled Trials [J] . Andersen Kathleen M., Cheah Jonathan T. L., March Lyn, The Journal of rheumatology . 2019,第8期

机译：从患者的角度提高疗效损害评估：Omeract关于随机对照试验的核心集合的共识
2. Early enteral supplementation with key pharmaconutrients improves Sequential Organ Failure Assessment score in critically ill patients with sepsis: Outcome of a randomized, controlled, double-blind trial. [J] . Beale RJ, Sherry T, Lei K, Critical care medicine . 2008,第1期

机译：早期肠内补充关键药物营养素可改善脓毒症危重患者的顺序器官衰竭评估评分：一项随机，对照，双盲试验的结果。
3. Early enteral supplementation with key pharmaconutrients improves Sequential Organ Failure Assessment score in critically ill patients with sepsis: Outcome of a randomized, controlled, double-blind trial [J] . JPEN. Journal of parenteral and enteral nutrition. . 2008,第6期

机译：早期肠内补充关键药物营养素可改善脓毒症危重患者的顺序器官衰竭评估评分：一项随机，对照，双盲试验的结果
4. Synbiotic Therapy Significantly Reduces Molecular Markers of Inflammation and Clinical Scores in Patients with Active Ulcerative Colitis; A Randomised Controlled Trial [C] . Controlled Release Society annual meeting . 2004

机译：同步治疗显着减少了活性溃疡性结肠炎患者的炎症和临床评分的分子标记;随机对照试验
5. Feasibility Study of a Randomized Controlled Trial Protocol to Examine the Effectiveness of Auriculotherapy (AT) in Improving Sleep Condition and Glycaemic Control in Clients with Type 2 Diabetes. [D] . Kwan, Yee Mei. 2013

机译：一项随机对照试验方案的可行性研究，以检查耳穴疗法（AT）改善2型糖尿病患者睡眠状况和血糖控制的有效性。
6. Selecting Core Outcomes for Randomised Effectiveness trials In Type 2 diabetes (SCORE-IT): a patient and healthcare professional consensus on a core outcome set for type 2 diabetes [O] . Nicola L Harman, John P H Wilding, Dave Curry, 2019

机译：选择用于2型糖尿病（SCORE-IT）的随机有效性试验的核心结果：患者和医疗保健专业人士对2型糖尿病核心结局的共识
7. Uptake of the OMERACT-OARSI Hip and Knee Osteoarthritis Core Outcome Set: Review of Randomized Controlled Trials from 1997 to 2017 [O] . Toby O. Smith, Michael Mansfield, Gillian A. Hawker, 2019

机译：摄取oberact-oarsi髋关节和膝关节骨关节炎核心结果集：1997年至2017年的随机对照试验回顾

Improving Benefit-harm Assessment of Therapies from the Patient Perspective: OMERACT Premeeting Toward Consensus on Core Sets for Randomized Controlled Trials

摘要

著录项

相似文献

相关主题

期刊订阅